Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Qin-Hua Zhao"'
Autor:
Qin‐Hua Zhao, Jun Chen, Fa‐Dong Chen, Hong‐Yun Ruan, Wei Zhang, Yan‐Li Zhou, Qi‐Qi Wang, Xiao‐Ling Xu, Ke‐Fu Feng, Jian‐Zhou Guo, Su‐Gang Gong, Rui‐Feng Zhang, Lan Wang
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract This study aimed to evaluate the effectiveness and safety of an oral sequential triple combination therapy with selexipag after dual combination therapy with endothelin receptor antagonist (ERA) and phosphodiesterase‐5 inhibitor (PDE5I)/ri
Externí odkaz:
https://doaj.org/article/0cadbfafa3bc41afbb7e5520273a0063
Autor:
Hui Zhao, Lan Wang, Yi Yan, Qin-Hua Zhao, Jing He, Rong Jiang, Ci-Jun Luo, Hong-Ling Qiu, Yu-Qing Miao, Su-Gang Gong, Ping Yuan, Wen-Hui Wu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Pulmonary fibrosis (PF) and pulmonary hypertension (PH) have common pathophysiological features, such as the significant remodeling of pulmonary parenchyma and vascular wall. There is no effective specific drug in clinical treatment for these two dis
Externí odkaz:
https://doaj.org/article/fcb79f85c3964aa58da2968899c06aab
Autor:
Xiu-Jun Zhong, Rong Jiang, Lu Yang, Ping Yuan, Su-Gang Gong, Qin-Hua Zhao, Ci-Jun Luo, Hong-Ling Qiu, Hui-Ting Li, Rui Zhang, Jing He, Lan Wang, Jie Tang, Jin-Ming Liu
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Pulmonary hypertension in left heart disease (PH-LHD), which includes combined post- and precapillary PH (Cpc-PH) and isolated postcapillary PH (Ipc-PH), differs significantly in prognosis. We aimed to assess whether cardiopulmona
Externí odkaz:
https://doaj.org/article/d31b1ecfbafb463e816083876b5629f3
Autor:
Qin-Hua Zhao, Su-Gang Gong, Jing He, Ping Yuan, Wen-Hui Wu, Ci-Jun Luo, Rong Jiang, Rui Zhang, Hong-Ling Qiu, Hui-Ting Li, Yuan Li, Jin-Ming Liu, Lan Wang
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract Background Management of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remains a clinical challenge. Currently, riociguat, a soluble guanylate-cyclase stimulator is recommended by international guidelines. More recently, b
Externí odkaz:
https://doaj.org/article/79cb40013f634c76956e1ebeb61bd0df
Autor:
Shang Wang, Zi-Yan Guo, Xing-Xing Sun, Ping Yuan, Qin-Hua Zhao, Wen-Hui Wu, Hong-Ling Qiu, Ci-Jun Luo, Su-Gang Gong, Hui-Ting Li, Rui Zhang, Jing He, Lan Wang, Jin-Ming Liu, Jian Guo, Rong Jiang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveWhether exercise-induced venous-to-systemic shunt (EIS) during cardiopulmonary exercise testing (CPET) has different manifestations or characteristics in idiopathic pulmonary arterial hypertension (IPAH) and chronic thromboembolic pulmonary
Externí odkaz:
https://doaj.org/article/a94a85a4898642ccb4a30158b73d8bd3
Autor:
Jie Li, Zu-Yuan Yang, Shang Wang, Ping Yuan, Qin-Hua Zhao, Su-Gang Gong, Hong-Ling Qiu, Ci-Jun Luo, Hui-Ting Li, Rui Zhang, Wen-Hui Wu, Jin-Ming Liu, Lan Wang, Shan-Shan Liu, Rong Jiang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundThere is little evidence of the effectiveness of switching from the endothelin receptor antagonists (ERAs) bosentan and ambrisentan to a novel ERA, macitentan, in patients with pulmonary arterial hypertension (PAH). Therefore, a systematic
Externí odkaz:
https://doaj.org/article/fdadc1eb72e843b08b336fa430c091fb
Autor:
Ci‐Jun Luo, Hong‐Ling Qiu, Chang‐Wei Wu, Jing He, Ping Yuan, Qin‐Hua Zhao, Rong Jiang, Wen‐Hui Wu, Su‐Gang Gong, Jian Guo, Rui Zhang, Jin‐Ming Liu, Lan Wang
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-8 (2021)
Cardiopulmonary exercise testing and pulmonary function test are important methods for detecting human cardio‐pulmonary function. Whether they could screen vasoresponsiveness in idiopathic pulmonary artery hypertension (IPAH) patients remains undef
Externí odkaz:
https://doaj.org/article/c8c6effbe62e431095c08b0cc69921a8
Autor:
Jin-Ling Li, Fan Xiao, Hong-Ting Liu, Hui-Ting Li, Qin-Hua Zhao, Chun-Yan Sun, Yan Zhu, Lei Yan, Wen-Yue Wang, Hui Luo, Su-Gang Gong, Rong Jiang, Jin-Ming Liu, Rui Zhang, Lan Wang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundSignificantly improved survival in patients with pulmonary hypertension (PH) has raised interest in maintaining a good quality of long-term survivorship. In this study, health-related quality of life (HRQOL) measurement was used to assess t
Externí odkaz:
https://doaj.org/article/95fa5656d297408aa55fae47b2b887c5
Autor:
Hui-Ting Li, Ping Yuan, Qin-Hua Zhao, Su-Gang Gong, Rong Jiang, Jin-Ling Li, Hong-Ting Liu, Hong-Ling Qiu, Wen-Hui Wu, Ci-Jun Luo, Jing He, Lan Wang, Jin-Ming Liu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveAlthough chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease (CTEPD) are known to be accompanied by symptoms associated with sleep-disordered breathing (SDB) and nocturnal hypoxemia, the sex-spe
Externí odkaz:
https://doaj.org/article/6a5ef6e87ade452290db99503ba684a1
Autor:
Rong Jiang, Lan Wang, Ping Yuan, Qin-Hua Zhao, Su-Gang Gong, Jing He, Hong-Ling Qiu, Ci-Jun Luo, Rui Zhang, Ting Shen, Meng-Yi Zhan, Yu-Mei Jiang, Fa-Dong Chen, Jin-Ming Liu, Yu-Qin Shen
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundPatients with pulmonary arterial hypertension (PAH) have reduced exercise capacity and poor quality of life. Exercise-based rehabilitation in PAH results in clinically relevant improvements in exercise capacity and hemodynamics. To clarify
Externí odkaz:
https://doaj.org/article/ee3621a151474f22a649f3ac78122fef